logo

For the Inventor, By the Inventor

Osaka, Japan

Minoru Hirata

This inventor holds 11 USPTO granted patents. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1979-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Minoru Hirata. Retrieved from https://idiyas.com/inventor/minoru-hirata-g0p6tdus

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 5

Forward Citations = 82(Granted Patents)


Location History:

  • Takatsuki, JP (1979 - 1980)
  • Ikeda, JP (1984 - 1990)
  • Osaka, JP (1988 - 1991)

Company Filing History:

goldMedal11 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents

Years Active: 1979-1991

Loading Chart...
11 patents (USPTO):Explore Patents
1. 4987130 - Substituted amine derivatives, their production and use (1991-01-22),
2. 4959362 - Pharmaceutical compositions containing certain ascorbic acid derivatives (1990-09-25),
3. 4939274 - Hydroxybutenolide derivatives, production and use thereof (1990-07-03),
4. 4925868 - 4-Hydroxy-3-pyrrolin-2-ones and treatment of circulatory disorders (1990-05-15),
5. 4780549 - Ascorbic acid derivatives and their production (1988-10-25),
6. 4751316 - 1,5-benzoxathiepin derivatives (1988-06-14),
7. 4736031 - 2-(piperazinylalkyl)-1-benzothiepin, 1-benzoxepin, and 1,5-benzodioxepin (1988-04-05),
8. 4672064 - 1,5-benzoxathiepin derivatives, their production and use (1987-06-09),
9. 4436753 - Method for therapy of ischemic disease (1984-03-13),
10. 4199582 - Piperazine containing dihydronaphthalene derivatives and compositions (1980-04-22),
11. 4148897 - 1,2-Dihydronaphthalene derivatives and pharmaceutical composition (1979-04-10),

Title: Minoru Hirata: Innovator in Pharmaceutical Chemistry

Introduction

Minoru Hirata is a distinguished inventor based in Osaka, Japan, known for his significant contributions to pharmaceutical chemistry. With a total of 11 patents to his name, he has made remarkable advancements in the field, particularly in the development of compounds with therapeutic applications.

Latest Patents

Hirata's latest patents include innovative compounds such as substituted amine derivatives, which have shown anti-arrhythmic activity. These compounds are represented by a specific formula and are useful for the prevention and treatment of various arrhythmias. Another notable patent involves pharmaceutical compositions containing certain ascorbic acid derivatives, which possess antioxidant properties and are beneficial for improving circulatory functions. These compounds are designed to serve as antioxidant agents for food and as agents for the prophylaxis and improvement of circulatory functional disorders.

Career Highlights

Minoru Hirata has built a successful career at Takeda Chemical Industries, Inc., where he has been instrumental in advancing research and development in pharmaceutical products. His work has not only contributed to the scientific community but has also had a significant impact on public health through the development of effective therapeutic agents.

Collaborations

Throughout his career, Hirata has collaborated with notable colleagues such as Shinji Terao and Hirosada Sugihara. These collaborations have fostered a productive environment for innovation and have led to the successful development of various pharmaceutical compounds.

Conclusion

Minoru Hirata's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in the field of medicine. His patents and collaborative efforts continue to pave the way for advancements that benefit society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…